Status: Recruiting
A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
This is a phase II, randomized, double-blinded, placebo-controlled study to treat patients with transfusion-dependent and non-transfusion dependent β -thalassemia with AND017 and optimal supportive care, including blood transfusion and iron removal, based on the clinician's judgment and practice.
Participants needed: 64
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Kind Pharmaceuticals LLCUpdated: Feb 27, 2026Locations: 5
Eligibility criteria
Documented diagnosis of β-thalassemia or hemoglobin E/β-thalassemia, HbS/ β-thal... [+6]
Other causes of anemia (e.g., hemolytic anemia, history of pure red blood cell a... [+9]